107OCrizotinib in advanced ROS1-rearranged non-small cell...

Annals of Oncology 2019 / 04 Vol. 30; Iss. Supplement

107OCrizotinib in advanced ROS1-rearranged non-small cell lung cancer (NSCLC): Overall survival (OS) and updated safety from PROFILE 1001

Shaw, A, Riely, G J, Bang, Y-J, Kim, D-W, Camidge, D R, Shapiro, G I, Usari, T, Wang, S C, Wilner, K, Clark, J W, Ou, S-H I
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz063.005
Date:
April, 2019
File:
PDF, 91 KB
english, 2019
Conversion to is in progress
Conversion to is failed